BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tosato G, Jones K, Breinig MK, McWilliams HP, McKnight JL. Interleukin-6 production in posttransplant lymphoproliferative disease. J Clin Invest 1993;91:2806-14. [PMID: 8514888 DOI: 10.1172/JCI116523] [Cited by in Crossref: 77] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Hopwood P, Crawford DH. The role of EBV in post-transplant malignancies: a review. J Clin Pathol 2000;53:248-54. [PMID: 10823119 DOI: 10.1136/jcp.53.4.248] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 3.8] [Reference Citation Analysis]
2 Khan MA, Mujahid M. Recent Advances in Electrochemical and Optical Biosensors Designed for Detection of Interleukin 6. Sensors (Basel) 2020;20:E646. [PMID: 31979357 DOI: 10.3390/s20030646] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
3 Jones K, Rivera C, Sgadari C, Franklin J, Max EE, Bhatia K, Tosato G. Infection of human endothelial cells with Epstein-Barr virus. J Exp Med 1995;182:1213-21. [PMID: 7595192 DOI: 10.1084/jem.182.5.1213] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 1.9] [Reference Citation Analysis]
4 Sakakibara S, Tosato G. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies. J Interferon Cytokine Res 2011;31:791-801. [PMID: 21767154 DOI: 10.1089/jir.2011.0043] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
5 Frey NV, Tsai DE. The management of posttransplant lymphoproliferative disorder. Med Oncol 2007;24:125-36. [PMID: 17848735 DOI: 10.1007/BF02698031] [Cited by in Crossref: 44] [Cited by in F6Publishing: 7] [Article Influence: 3.1] [Reference Citation Analysis]
6 Pegoraro F, Favre C. Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation. Ann Hematol 2021;100:865-78. [PMID: 33547921 DOI: 10.1007/s00277-021-04433-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Tanner JE, Alfieri C, Chatila TA, Diaz-Mitoma F. Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220. J Virol 1996;70:570-5. [PMID: 8523572 DOI: 10.1128/JVI.70.1.570-575.1996] [Cited by in Crossref: 40] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
8 Megyola C, Ye J, Bhaduri-McIntosh S. Identification of a sub-population of B cells that proliferates after infection with Epstein-Barr virus. Virol J 2011;8:84. [PMID: 21352549 DOI: 10.1186/1743-422X-8-84] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
9 Faro A. Interferon-alpha and its effects on post-transplant lymphoproliferative disorders. Springer Semin Immunopathol 1998;20:425-36. [PMID: 9870255 DOI: 10.1007/BF00838053] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]